Neptune Wellness Solutions Inc. Stock Toronto S.E.
Equities
NEPT
CA64079L2049
Pharmaceuticals
Sales 2022 | 48.8M 35.58M | Sales 2023 | 52.62M 38.37M | Capitalization | 6.36M 4.64M |
---|---|---|---|---|---|
Net income 2022 | -75M -54.69M | Net income 2023 | -60M -43.75M | EV / Sales 2022 | 0.97 x |
Net Debt 2022 | 5.61M 4.09M | Net Debt 2023 | 23.3M 16.99M | EV / Sales 2023 | 0.56 x |
P/E ratio 2022 |
-0.5
x | P/E ratio 2023 |
-0.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58.01% |
1st Jan change | Capi. | |
---|---|---|
+20.15% | 3.56B | |
+112.55% | 2.02B | |
+80.95% | 59.43M | |
+265.38% | 54.09M |